Antiretroviral therapy: A key component of a comprehensive HIV prevention strategy

Current HIV/AIDS Reports

Volumn 8, Issue 2, 2011, Pages 85-93

  Hull, Mark W ^a   Montaner, Julio ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antiretroviral therapy; HIV transmission; Mathematical models; Serodiscordant couples; Treatment as prevention

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; COST EFFECTIVENESS ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MATHEMATICAL MODEL; MORBIDITY; MORTALITY; RISK REDUCTION; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; VIRAL LOAD;

EID: 79957533066     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-011-0076-6     Document Type: Article

References (59)

1. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. MMWR 1981;30(25):305-8, Jul 3.
2. UNAIDS. Report on the global AIDS epidemic. 2010.
3. SM Hammer KE Squires MD Hughes, et al. 1997 A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team NEngl J Med 337 11 725 33 10.1056/NEJM199709113371101 1:CAS:528:DyaK2sXmt1yit7o%3D (Pubitemid 27417971)
4. N Lohse AB Hansen G Pedersen, et al. 2007 Survival of persons with and without HIV infection in Denmark, 1995-2005 Ann Intern Med 146 2 87 95 17227932 (Pubitemid 351640011)
5. HI Hall R Song P Rhodes, et al. 2008 Estimation of HIV incidence in the United States JAMA 300 5 520 9 18677024 10.1001/jama.300.5.520 1:CAS:528:DC%2BD1cXps1ygtrY%3D
6. RC Bailey S Moses CB Parker, et al. 2007 Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial Lancet 369 9562 643 56 17321310 10.1016/S0140-6736(07)60312-2 (Pubitemid 46281312)
7. RH Gray G Kigozi D Serwadda, et al. 2007 Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial Lancet 369 9562 657 66 17321311 10.1016/S0140-6736(07)60313-4
8. ••Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329(5996):1168-74, New York, NY Sep 3. First clinical trial documenting that a vaginal preparation of tenofovir was associated with decreased transmission of HIV.
9. SP Buchbinder DV Mehrotra A Duerr, et al. 2008 Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial Lancet 372 9653 1881 93 19012954 10.1016/S0140-6736(08)61591-3 1:CAS:528:DC%2BD1cXhsVelurfM
10. S Rerks-Ngarm P Pitisuttithum S Nitayaphan, et al. 2009 Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand N Engl J Med 361 23 2209 20 19843557 10.1056/NEJMoa0908492 1:CAS:528:DC%2BD1MXhsFWhsb%2FO
11. CL Townsend M Cortina-Borja CS Peckham A de Ruiter H Lyall PA Tookey 2008 Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006 AIDS (London, England) 22 8 973 81 10.1097/QAD.0b013e3282f9b67a (Pubitemid 351652248)
12. TC Quinn MJ Wawer N Sewankambo, et al. 2000 Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group N Engl J Med 342 13 921 9 10738050 10.1056/NEJM200003303421303 1:STN:280:DC%2BD3c7otlWjsA%3D%3D (Pubitemid 30177052)
13. S Tovanabutra V Robison J Wongtrakul, et al. 2002 Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand JAIDS (1999) 29 3 275 83 (Pubitemid 34208536)
14. H Zhang G Dornadula M Beumont, et al. 1998 Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy N Engl J Med 339 25 1803 9 9854115 10.1056/NEJM199812173392502 1:STN:280: DyaK1M%2FmtFShsQ%3D%3D (Pubitemid 29005784)
15. MS Cohen C Gay AD Kashuba S Blower L Paxton 2007 Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1 Ann Intern Med 146 8 591 601 17438318 (Pubitemid 351650540)
16. SM Graham SE Holte NM Peshu, et al. 2007 Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding AIDS (London, England) 21 4 501 7 10.1097/QAD.0b013e32801424bd
17. DJ Chan JE Ray L McNally M Batterham DE Smith 2008 Correlation between HIV-1 RNA load in blood and seminal plasma depending on antiretroviral treatment status, regimen and penetration of semen by antiretroviral drugs Curr HIV Res 6 5 477 84 18855660 10.2174/157016208785861177 1:CAS:528:DC%2BD1cXhtlWgu7fE
18. J Ghosn JP Viard C Katlama, et al. 2004 Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men AIDS (London, England) 18 3 447 57 10.1097/00002030-200402200-00011 1:CAS:528:DC%2BD2cXjsFSksb0%3D (Pubitemid 38365872)
19. G Liuzzi A Chirianni M Zaccarelli, et al. 2004 Differences between semen and plasma of nucleoside reverse transcriptase resistance mutations in HIV-infected patients, using a rapid assay In vivo (Athens, Greece) 18 4 509 12 1:CAS:528:DC%2BD2cXotFWqu7k%3D (Pubitemid 39200000)
20. AG Marcelin R Tubiana S Lambert-Niclot, et al. 2008 Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma AIDS (London, England) 22 13 1677 9 10.1097/QAD.0b013e32830abdc8
21. G Lorello C la Porte R Pilon G Zhang T Karnauchow P MacPherson 2009 Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma HIV Med 10 9 548 54 19515092 10.1111/j.1468-1293.2009.00725.x 1:CAS:528:DC%2BD1MXhtlGgtLfF
22. •Sheth PM, Kovacs C, Kemal KS, et al. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS (London, England) 2009;23(15):2050-4, Sep 24. Cohort study of men initiating antiretroviral therapy documenting intermittent detectable viral loads in seminal fluid despite suppression of plasma viral load.
23. SC Kalichman G Di Berto L Eaton 2008 Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings Sex Transm Dis 35 1 55 60 18217225 10.1097/OLQ.0b013e318141fe9b (Pubitemid 351619353)
24. J Castilla J Del Romero V Hernando B Marincovich S Garcia C Rodriguez 2005 Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV JAIDS (1999) 40 1 96 101 10.1097/01.qai. 0000157389.78374.45 (Pubitemid 41233212)
25. Sullivan PS, Kayetinkore K, Chomba E et al. Reduction of HIV Transmission Risk and High Risk Sex while Prescribed ART: Results from Discordant Couples in Rwanda and Zambia. [abstract52bLB]. Presented at the 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada; February 8-11, 2009.
26. C Celum A Wald JR Lingappa, et al. 2010 Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2 N Engl J Med 362 5 427 39 20089951 10.1056/NEJMoa0904849 1:CAS:528:DC%2BC3cXhvVams70%3D
27. JR Lingappa JM Baeten A Wald, et al. 2010 Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial Lancet 375 9717 824 33 20153888 10.1016/S0140-6736(09)62038-9 1:CAS:528:DC%2BC3cXivFegsrk%3D
28. ••Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010;375(9731):2092-8, Jun 12. Cohort study nested with the HSV suppression trial which demonstrates that provision of HAART in the setting of heterosexual discordant couples was associated with reduced sexual transmission.
29. •Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (London, England) 2009;23(11):1397-404, Jul 17. Important meta-analysis of heterosexual transmission of HIV.
30. L Wang Z Ge J Luo, et al. 2010 HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China JAIDS (1999) 55 2 232 8 10.1097/QAI.0b013e3181e9b6b7
31. Fox J, Fidler S. Sexual transmission of HIV-1. Antiviral Res;85(1):276-85, Jan.
32. RF Baggaley RG White MC Boily 2010 HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention Int J Epidemiol 39 4 1048 63 20406794 10.1093/ije/dyq057
33. •Jin F, Jansson J, Law M, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010 (London, England) 24(6):907-13, Mar 27. This study assessed per-contact transmission of HIV among MSM. Transmission rates remain similar to other pre-HAART estimates, despite assumed acceptable uptake of HAART in the community.
34. K Falster L Gelgor A Shaik, et al. 2008 Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment Sex Health 5 2 141 54 18588779 10.1071/SH07082 (Pubitemid 351786449)
35. DP Wilson F Jin J Jansson I Zablotska AE Grulich 2010 Infectiousness of HIV-infected men who have sex with men in the era of highly active antiretroviral therapy AIDS 24 15 2420 1 20827060 10.1097/QAD.0b013e32833dbdb1
36. RF Baggaley C Fraser 2010 Modelling sexual transmission of HIV: testing the assumptions, validating the predictions Curr Opin HIV AIDS 5 4 269 76 20543600 10.1097/COH.0b013e32833a51b2
37. SM Blower HB Gershengorn RM Grant 2000 A tale of two futures: HIV and antiretroviral therapy in San Francisco Science (New York, NY) 287 5453 650 4 10.1126/science.287.5453.650 1:CAS:528:DC%2BD3cXovVyisA%3D%3D (Pubitemid 30070912)
38. JX Velasco-Hernandez HB Gershengorn SM Blower 2002 Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis 2 8 487 93 12150848 10.1016/S1473-3099(02)00346-8 1:STN:280: DC%2BD38vgt1Ckuw%3D%3D (Pubitemid 34826854)
39. MS Cohen CL Gay 2010 Treatment to prevent transmission of HIV-1 Clin Infect Dis 50 Suppl 3 S85 95 20397961 10.1086/651478
40. •Lima VD, Johnston K, Hogg RS, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. Journal of Infectious Diseases 2008;198(1):59-67, Jul 1. Mathematical model demonstrating potential reduction in HIV diagnoses linked to expanding HAART coverage within 2006 guideline parameters. (Pubitemid 351920290)
41. VD Lima RS Hogg JS Montaner 2010 Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada PLoS ONE 5 6 e10991 20539817 10.1371/journal.pone.0010991
42. ••Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009 Jan 3;373(9657):48-57. Important mathematical model set in South Africa examining a test and treat approach to eliminating the HIV epidemic within Africa.
43. PJ Dodd GP Garnett TB Hallett 2010 Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings AIDS (London, England) 24 5 729 35 10.1097/QAD.0b013e32833433fe
44. •Walensky RP, Paltiel AD, Losina E, et al. Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis 2010;51(4):392-400, Aug 15. Mathematical model of test and treat assumptions within Washington, DC. While expansion of HAART was associated with decreased transmission, it was unlikely to halt the epidemic.
45. •Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 2009;338:b1649. Assessment of effects of community viral load and time to HIV seroconversion. After community viral load was reduced, there was no longer a statistically significant association with HIV incidence.
46. ••Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PloS One 2010;5(6):e11068. Assessment of community viral load and new HIV diagnoses in San Francisco. HAART expansion and reduction in viral load was associated with decrease in new HIV diagnoses.
47. ••Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010;376(9740):532-9, Aug 14. Population-based Canadian study documenting that expansion of HAART was associated with decreases in community viral load and decreases in new HIV diagnoses.
48. CS Morrison K Demers C Kwok, et al. 2010 Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection AIDS (London, England) 24 4 573 82 10.1097/QAD.0b013e32833433df
49. MJ Wawer RH Gray NK Sewankambo, et al. 2005 Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda J Infect Dis 191 9 1403 9 15809897 10.1086/429411 (Pubitemid 40563350)
50. TD Hollingsworth RM Anderson C Fraser 2008 HIV-1 transmission, by stage of infection J Infect Dis 198 5 687 93 18662132 10.1086/590501
51. VS Prabhu AB Hutchinson PG Farnham SL Sansom 2009 Sexually acquired HIV infections in the United States due to acute-phase HIV transmission: an update AIDS (London, England) 23 13 1792 4 10.1097/QAD.0b013e32832e7d04
52. BD Marshall MJ Milloy T Kerr R Zhang JS Montaner E Wood 2010 No evidence of increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs AIDS (London, England) 24 14 2271 8 10.1097/QAD.0b013e32833dd101
53. KK Venkatesh G de Bruyn MN Lurie, et al. 2010 Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics AIDS (London, England) 24 17 2687 96 10.1097/QAD.0b013e32833e78d4
54. RJ Smith JT Okano JS Kahn EN Bodine S Blower 2010 Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco Science (New York, NY) 327 5966 697 701 10.1126/science.1180556 1:CAS:528:DC%2BC3cXhtlyiu7c%3D
55. VS Gill VD Lima W Zhang, et al. 2010 Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection Clin Infect Dis 50 1 98 105 19951169 10.1086/648729 1:CAS:528:DC%2BC3cXhsVymtrg%3D
56. KM Johnston AR Levy VD Lima, et al. 2010 Expanding access to HAART: a cost-effective approach for treating and preventing HIV AIDS (London, England) 24 12 1929 35 10.1097/QAD.0b013e32833af85d
57. TJ Coates L Richter C Caceres 2008 Behavioural strategies to reduce HIV transmission: how to make them work better Lancet 372 9639 669 84 18687459 10.1016/S0140-6736(08)60886-7
58. SJ Reynolds TC Quinn 2010 Setting the stage: current state of affairs and major challenges Clin Infect Dis 50 Suppl 3 S71 6 20397959 10.1086/651476
59. CT Fang HM Hsu SJ Twu, et al. 2004 Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan J Infect Dis 190 5 879 85 15295691 10.1086/422601 (Pubitemid 39120963)